Johnson & Johnson Management

Management criteria checks 2/4

Johnson & Johnson's CEO is Joaquin Duato, appointed in Jan 2022, has a tenure of 2.83 years. total yearly compensation is $28.40M, comprised of 5.6% salary and 94.4% bonuses, including company stock and options. directly owns 0.015% of the company’s shares, worth CA$79.01M. The average tenure of the management team and the board of directors is 5 years and 4.9 years respectively.

Key information

Joaquin Duato

Chief executive officer

US$28.4m

Total compensation

CEO salary percentage5.6%
CEO tenure2.8yrs
CEO ownership0.02%
Management average tenure5yrs
Board average tenure4.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Joaquin Duato's remuneration changed compared to Johnson & Johnson's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 29 2024n/an/a

US$15b

Jun 30 2024n/an/a

US$16b

Mar 31 2024n/an/a

US$17b

Dec 31 2023US$28mUS$2m

US$13b

Oct 01 2023n/an/a

US$12b

Jul 02 2023n/an/a

US$12b

Apr 02 2023n/an/a

US$11b

Jan 01 2023US$13mUS$1m

US$16b

Oct 02 2022n/an/a

US$18b

Jul 03 2022n/an/a

US$17b

Apr 03 2022n/an/a

US$20b

Jan 02 2022US$14mUS$1m

US$18b

Oct 03 2021n/an/a

US$18b

Jul 04 2021n/an/a

US$18b

Apr 04 2021n/an/a

US$15b

Jan 03 2021n/an/a

US$15b

Sep 27 2020n/an/a

US$17b

Jun 28 2020n/an/a

US$15b

Mar 29 2020n/an/a

US$17b

Dec 29 2019US$13mUS$970k

US$15b

Sep 29 2019n/an/a

US$14b

Jun 30 2019n/an/a

US$16b

Mar 31 2019n/an/a

US$15b

Dec 30 2018US$9mUS$934k

US$15b

Sep 30 2018n/an/a

US$2b

Jul 01 2018n/an/a

US$1b

Apr 01 2018n/an/a

US$1b

Dec 31 2017US$19mUS$897k

US$1b

Compensation vs Market: Joaquin's total compensation ($USD28.40M) is above average for companies of similar size in the Canadian market ($USD7.94M).

Compensation vs Earnings: Joaquin's compensation has increased by more than 20% in the past year.


CEO

Joaquin Duato (61 yo)

2.8yrs

Tenure

US$28,397,240

Compensation

Mr. Joaquin Duato serves as Chief Executive Officer & Director of Johnson & Johnson since January 3, 2022 and serves as its Chairman since January 02, 2023. He served as Worldwide Chairman of Pharmaceutica...


Leadership Team

NamePositionTenureCompensationOwnership
Joaquin Duato
CEO & Chairman2.8yrsUS$28.40m0.015%
CA$ 79.0m
Joseph Wolk
Executive VP & CFO6.3yrsUS$13.91m0.0029%
CA$ 15.4m
Peter Fasolo
Executive VP & Chief Human Resources Officer8.6yrsUS$7.50m0.0047%
CA$ 24.3m
Jennifer Taubert
Executive VP & Worldwide Chairman of Innovative Medicine12.8yrsUS$11.00m0.0064%
CA$ 33.6m
John Reed
Executive Vice President of Innovative Medicine1.6yrsUS$20.65m0.00061%
CA$ 3.2m
Robert Decker
Controller & Chief Accounting Officer4.9yrsno data0.00082%
CA$ 4.3m
James Swanson
Executive VP & Chief Information Officer5yrsno data0.00061%
CA$ 3.2m
Jessica Moore
Vice President of Investor Relations3yrsno datano data
Dirk Brinckman
Chief Compliance Officerno datano datano data
Elizabeth Forminard
Executive VP & Chief Legal Officer2.1yrsno data0.00035%
CA$ 1.8m
Guy Lebeau
Group Chairman of MD&D Business - EMEAno datano datano data
Kathryn Wengel
Executive VP and Chief Technical Operations & Risk Officer6.3yrsno data0.0034%
CA$ 17.9m

5.0yrs

Average Tenure

58yo

Average Age

Experienced Management: JNJ's management team is considered experienced (5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Joaquin Duato
CEO & Chairman2.8yrsUS$28.40m0.015%
CA$ 79.0m
Anne Mulcahy
Independent Director15.8yrsUS$410.00k0.00034%
CA$ 1.8m
Hubert Joly
Independent Director4.9yrsUS$320.00k0.00021%
CA$ 1.1m
Marillyn Hewson
Lead Independent Director5.6yrsUS$360.00k0.00012%
CA$ 626.6k
Paula Johnson
Independent Director1.8yrsUS$352.97k0.000010%
CA$ 52.2k
Mark McClellan
Independent Director11.1yrsUS$320.00k0%
CA$ 0
Mary Beckerle
Independent Director9.4yrsUS$355.00k0%
CA$ 0
Darius Adamczyk
Independent Director2.8yrsUS$340.00k0.000040%
CA$ 208.9k
Jennifer Doudna
Independent Director6.6yrsUS$320.00k0%
CA$ 0
Eugene Woods
Independent Directorless than a yearUS$89.15kno data
Mark Weinberger
Independent Director4.9yrsUS$340.00k0%
CA$ 0
Nadja West
Independent Director3.9yrsUS$340.00k0%
CA$ 0

4.9yrs

Average Tenure

62.5yo

Average Age

Experienced Board: JNJ's board of directors are considered experienced (4.9 years average tenure).